Osamu Nagayama

Chairman & Chief Executive Officer of Chugai at Roche Holding AG

Osamu Nagayama

Osamu Nagayama

Chairman & Chief Executive Officer of Chugai at Roche Holding AG

Overview
Career Highlights

Chugai Pharmaceutical Co., Ltd.

RelSci Relationships

1196

Number of Boards

6

Birthday

04/1947

Age

73

Relationships
RelSci Relationships are individuals Osamu Nagayama likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Roche Holding AG

Relationship likelihood: Strong

Chairman & Chief Executive Officer at Chugai Pharmaceutical Co., Ltd.

Relationship likelihood: Strong

Chief Financial & Information Technology Officer at Roche Holding AG

Relationship likelihood: Strong

Honorary Professor at University of St. Gallen

Relationship likelihood: Strong

Vice Chairman at ScienceIndustries

Relationship likelihood: Strong

Head-Group Human Resources at Roche Holding AG

Relationship likelihood: Strong

Member of the Enlarged Corporate Executive Committee, Global Head Pharma Partnering at Roche Holding AG

Relationship likelihood: Strong

Former Director at Roche Holding AG

Relationship likelihood: Strong

Venture Partner & Senior Advisor at Pappas Capital LLC

Relationship likelihood: Strong

Former Head-Group Communications at Roche Holding AG

Relationship likelihood: Strong

Paths to Osamu Nagayama
Potential Connections via
Relationship Science
You
Osamu Nagayama
Chairman & Chief Executive Officer of Chugai at Roche Holding AG
Education
Faculty of Business & Commerce

Keio University's mission is to be a source of honorable character and a paragon of intellect and morals

Career History
Chairman & Chief Executive Officer of Chugai
Current

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

Chairman of the Board of Directors, Independent Director
Current

The Sony Group is primarily focused on the Electronics (such as AV/IT products & components), Game (such as PlayStation), Entertainment (such as motion pictures and music), and Financial Services (such as insurance and banking) sectors. Not only do we represent a wide range of businesses, but we remain globally unique. Our aim is to fully leverage this uniqueness in aggressively carrying out our convergence strategy so that we can continue to emotionally touch and excite our customers.

Chairman & Chief Executive Officer, Chugai
Current

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Osamu Nagayama. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Osamu Nagayama's profile does not indicate a business or promotional relationship of any kind between RelSci and Osamu Nagayama.